|
|
???tair.name??? >
???browser.page.title.author???
|
"pu y s"???jsp.browse.items-by-author.description???
Showing items 571-620 of 627 (13 Page(s) Totally)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2019-11-12T07:36:33Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Lin W.-C.;Kuo K.-L.;Shi C.-S.;Wu J.-T.;Hsieh J.-T.;Chang H.-C.;Liao S.-M.;Chou C.-T.;Chiang C.-K.;Chiu W.-S.;Chiu T.-Y.;Pu Y.-S.;Ho I.-L.;Wang Z.-H.;Chang S.-C.;Shing-Hwa Liu;Jeng Y.-M.;Huang K.-H.; Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; SHING-HWA LIU; Jeng Y.-M.; Huang K.-H. |
| 臺大學術典藏 |
2019 |
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral center
|
Chow P.-M.;Pu Y.-S.;Chang H.-C.;Huang C.-Y.;Huang K.-H.;Hung S.-C.;YU-CHUAN LU;Chiang I.-N.;Chen C.-H.;Hong C.-H.;Tai T.-E.;Tseng C.-S.; Tseng C.-S.; Tai T.-E.; Hong C.-H.; Chen C.-H.; Chiang I.-N.; YU-CHUAN LU; Hung S.-C.; Huang K.-H.; Huang C.-Y.; Chang H.-C.; Pu Y.-S.; Chow P.-M. |
| 臺大學術典藏 |
2019 |
Nuclear factor-�eB overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer
|
Cheng J.C.-H.; Lin C.-C.; Pu Y.-S.; Huang C.-Y.; YU-CHIEH TSAI; Wang C.-C.; Chiang Y. |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma
|
Huang, C.-Y.;Lin, Y.-C.;Shiue, H.-S.;Chen, W.-J.;Su, C.-T.;Pu, Y.-S.;Ao, P.-L.;Hsueh, Y.-M.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Impact of high-volume disease in Asian population with newly diagnosed metastatic prostate cancer
|
Cheng, Y.-T.;Hong, J.-H.;Lu, Y.-C.;Pu, Y.-S.;Huang, C.-Y.;Huang, K.-H.;Liu, S.;Chen, C.-H.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
|
Springer, S.U.;Chen, C.-H.;Del Carmen Rodriguez Pena, M.;Li, L.;Douville, C.;Wang, Y.;Cohen, J.D.;Taheri, D.;Silliman, N.;Schaefer, J.;Ptak, J.;Dobbyn, L.;Papoli, M.;Kinde, I.;Afsari, B.;Tregnago, A.C.;Bezerra, S.M.;Vandenbussche, C.;Fujita, K.;Ertoy, D.;Cunha, I.W.;Yu, L.;Bivalacqua, T.J.;Grollman, A.P.;Diaz, L.A.;Karchin, R.;Danilova, L.;Huang, C.-Y.;Shun, C.-T.;Turesky, R.J.;Yun, B.H.;Rosenquist, T.A.;Pu, Y.-S.;Hruban, R.H.;Tomasetti, C.;Papadopoulos, N.;Kinzler, K.W.;Vogelstein, B.;Dickman, K.G.;Netto, G.J.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Outcomes of prostate atypical small acinar proliferation and high-grade prostate intraepithelial neoplasm patients
|
Tung, S.-Y.;Pu, Y.-S.;Huang, C.-Y.;Chang, H.-C.;Huang, K.-H.;Wang, S.-M.;Tai, H.-C.;Chen, C.-H.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
Polymorphisms of TNF-�\ -308 G/A and IL-8 -251 T/A Genes Associated with Urothelial Carcinoma: A Case-Control Study
|
Wu, C.-C.;Huang, Y.-K.;Huang, C.-Y.;Shiue, H.-S.;Pu, Y.-S.;Su, C.-T.;Lin, Y.-C.;Hsueh, Y.-M.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:39Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng, Y.-T.;Chiang, C.-H.;Pu, Y.-S.;Liu, S.P.;Lu, Y.-C.;Chang, Y.-K.;Chang, H.-C.;Huang, K.-H.;Lee, Y.-J.;Chow, P.-M.;Hung, S.-C.;Huang, C.-Y.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:07:38Z |
Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma
|
Hsueh, Y.-M.;Chen, W.-J.;Lin, Y.-C.;Huang, C.-Y.;Shiue, H.-S.;Yang, S.-M.;Ao, P.-L.;Pu, Y.-S.;Su, C.-T.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T15:34:59Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang, Y.;Cheng, J.C.H.;Huang, C.-Y.;Tsai, Y.-C.;Lin, C.-C.;Hsu, C.-H.;Cheng, A.-L.;Pu, Y.-S.; CHAO-YUAN HUANG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T15:34:59Z |
Analysis of transrectal and suprapubic ultrasonography for prostate size evaluation
|
Feng, K.-K.;Chiang, I.-N.;Huang, C.-Y.;Pu, Y.-S.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T15:34:14Z |
Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma
|
Yang, S.-M.;Huang, C.-Y.;Shiue, H.-S.;Pu, Y.-S.;Hsieh, Y.-H.;Chen, W.-J.;Lin, Y.-C.;Hsueh, Y.-M.; Yang, S.-M.; Huang, C.-Y.; Shiue, H.-S.; Pu, Y.-S.; Hsieh, Y.-H.; Chen, W.-J.; Lin, Y.-C.; Hsueh, Y.-M.; CHAO-YUAN HUANG; YEONG-SHIAU PU; Chen, Wei-Jen |
| 臺大學術典藏 |
2018-09-10T15:28:01Z |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Lin, W.-C.;Kuo, K.-L.;Shi, C.-S.;Wu, J.-T.;Hsieh, J.-T.;Chang, H.-C.;Liao, S.-M.;Chou, C.-T.;Chiang, C.-K.;Chiu, W.-S.;Chiu, T.-Y.;Pu, Y.-S.;Ho, I.-L.;Wang, Z.-H.;Chang, S.-C.;Liu, S.-H.;Jeng, Y.-M.;Huang, K.-H.; WEI-CHOU LIN |
| 臺大學術典藏 |
2018-09-10T15:25:16Z |
Prognostic value of saturated prostate cryoablation for localized prostate cancer
|
Chen, C.-H.; Tai, Y.-S.; Pu, Y.-S.; Chen, Chung-Hsin; Tai, Yi-Sheng; Pu, Yeong-Shiau; 蒲永孝; 陳忠信; Chen, Chung-Hsin; CHUNG-HSIN CHEN; Pan, Kuo-Long; Tseng, Kun-Cheng; Tai, Yi-Sheng; YEONG-SHIAU PU; Wang, Ching-Hua; Pu, Yeong-Shiau |
| 臺大學術典藏 |
2018-09-10T07:45:19Z |
Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma
|
Huang, S.K. and Chiu, A.W.-H. and Pu, Y.-S. and Huang, Y.-K. and Chung, C.-J. and Tsai, H.-J. and Yang, M.-H. and Chen, C.-J. and Hsueh, Y.-M.; Huang, S.K.; Chiu, A.W.; Pu, Y.S.; Huang, Y.K.; Chung, C.J.; Tsai, H.J.; Yang, M.H.; Chen, C.J.; Hsueh, Y.M.; 黃冠華;邱文祥;蒲永孝;黃詠愷;鍾季容;蔡蕙如;楊末雄;陳建仁;薛玉梅; HUAN, STEVEN KUAN-HUA;CHIU, ALLEN WEN-HSIANG;PU, YEONG-SHIAU;HUANG, YUNG-KAI;CHUNG, CHI-JUNG;TSAI, HUI-JU;YANG, MO-HSIUNG;CHEN, CHIEN-JEN;HSUEH, YU-MEI; Chang, Chia-Hsuin; YEONG-SHIAU PU; Huang, S.K.; Chen, Hsi-Chieh; Chiu, A.W.; 邱文祥; Pu, Y.S.; Caffrey, James L.; Hsu, Jiun; Huang, Y.K.; Chung, C.J.; Lin, Jou-Wei; Tsai, H.J.; Lai, Mei-Shu; Yang, M.H.; Chen, Yih-Sharng; Chen, C.J.; 陳益祥; Hsueh, Y.M.; 賴美淑; HUAN, STEVEN KUAN-HUA; 張家勳; CHIU, ALLEN WEN-HSIANG; 張家豪; 許鈞; PU, YEONG-SHIAU; 林昭維; HUANG, YUNG-KAI; CHUNG, CHI-JUNG; TSAI, HUI-JU; YANG, MO-HSIUNG; CHEN, CHIEN-JEN; HSUEH, YU-MEI |
| 臺大學術典藏 |
2018-09-10T05:59:59Z |
Primary amyloidosis of the urinary bladder
|
Huang, C.-Y.;Shun, C.-T.;Huang, K.-H.;Chen, J.;Pu, Y.-S.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T05:59:58Z |
Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer
|
Hour, T.-C.;Pu, Y.-S.;Lin, C.-C.;Huang, S.-W.;Chen, J.;Chiu, A.W.;Chen, C.-J.;Huang, C.-Y.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T03:51:09Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen, A.-L.;Hsu, C.-H.;Lin, J.-K.;Hsu, M.-M.;Ho, Y.-F.;She, T.-S.;Ko, J.-Y.;Lin, J.-T.;Lin, B.-R.;Wu, M.-S.;Yu, H.-S.;Jee, S.-H.;Chen, G.-S.;Chen, T.-M.;Chen, C.-A.;Lai, M.-K.;Pu, Y.-S.;Pan, M.-H.;Wang, Y.-J.;Tsai, C.-C.;Hsieh, C.-Y.; SHIOU-HWA JEE |
| 臺大學術典藏 |
2018-09-10T03:48:44Z |
Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells
|
Pu, Y.-S.;Chen, J.;Huang, C.-Y.;Guan, J.-Y.;Lu, S.-H.;Hour, T.-C.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T03:48:44Z |
Effect of percent free prostate-specific antigen measurement on improving the specificity of serum prostate-specific antigen testing in Taiwanese patients
|
Liao, C.-H.;Liu, S.-P.;Pu, Y.-S.;Huang, C.-Y.;Yu, H.-J.;Chen, J.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T03:42:06Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen, A.-L.;Hsu, C.-H.;Lin, J.-K.;Hsu, M.-M.;Ho, Y.-F.;She, T.-S.;Ko, J.-Y.;Lin, J.-T.;Lin, B.-R.;Wu, M.-S.;Yu, H.-S.;Jee, S.-H.;Chen, G.-S.;Chen, T.-M.;Chen, C.-A.;Lai, M.-K.;Pu, Y.-S.;Pan, M.-H.;Wang, Y.-J.;Tsai, C.-C.;Hsieh, C.-Y.; YUNN-FANG HO |
| 臺大學術典藏 |
2018 |
Impact of high-volume disease in Asian population with newly diagnosed metastatic prostate cancer
|
Liu S.; Chen C.-H.; Huang K.-H.; Huang C.-Y.; Pu Y.-S.; Lu Y.-C.; JIAN-HUA HONG; Cheng Y.-T. |
| 臺大學術典藏 |
2017 |
Increased risk of new-onset hypertension after shock wave lithotripsy in urolithiasis: A nationwide cohort study
|
KUO-LIONG CHIEN; Huang C.-Y.; Chen P.-C.; Pu Y.-S.; Wang J.; Tsai C.-Y.; Huang S.-W. |
| 國立臺灣大學 |
2016 |
Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study
|
Ye, D.; Ahn, H.; Pu, Y-S.; Weiqing, H.; Xie, L-P.; Huang, S-P.; Wu, H-C.; Ma, L.; Yamada, S.; Noda, S.; Sun, Y.; 蒲永孝 |
| 國立臺灣大學 |
2016 |
Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study
|
Ye, D.; Ahn, H.; Pu, Y-S.; Han, W.; Xie, L-P.; Huang, S-P.; Wu, H-C.; Ma, L.; Qi, J.; Zhou, F.; Sun, G.; Chen, L.; Xue, B.; Yamada, S.; Saito, M.; Suga, K.; Sun, Y.; 蒲永孝 |
| 臺大學術典藏 |
2016 |
Volume alteration of undescended testes: Before and after orchiopexy
|
CHIANG I-NI; Pu Y.-S.; Huang K.-H.; Tseng C.-S. |
| 臺大學術典藏 |
2016 |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Liu S.-P.; Lai M.-K.; Pu Y.-S.; CHIA-HSIEN CHENG; Yu H.-J.; Chen C.-H.; Lan K.-H.; Wang C.-C.; Huang C.-Y.; Hou W.-H.; Hou W.-H.;Huang C.-Y.;Wang C.-C.;Lan K.-H.;Chen C.-H.;Yu H.-J.;Liu S.-P.;Lai M.-K.;Pu Y.-S.;Chia-Hsien Cheng |
| 臺大學術典藏 |
2016 |
Recommended initial antimicrobial therapy for emphysematous pyelonephritis
|
Lu Y.-C.; Hong J.-H.; Chiang B.-J.; Pong Y.-H.; PO-REN HSUEH; Huang C.-Y.; Pu Y.-S. |
| 國立臺灣大學 |
2015 |
A multicenter, prospective, longitudinal registry of prostate cancer in Asia
|
Uemura, H.; Ye, D.; Wu, T-L.; Lee, J-Y.; Chong, Y. L.; Razack, A. H. A.; Pripatnanont, C.; Chiong, E.; Lau, W. K. O.; Kanesvaran, R.; Li, C.; Rawal, S.; Tongaonkar, H.; Pu, Y-S.; Santingamkun, A.; Lojanapiwat, B.; Liang, H.; Mah, K. W.; Losio, M. van Kooten; Liu, Y.; 蒲永孝 |
| 臺大學術典藏 |
2015 |
MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study
|
Lin, W.-C. ; Kuo, K.-L. ; Shi, C.-S. ; Wu, J.-T. ; Hsieh, J.-T. ; Chang, H.-C. ; Liao, S.-M. ; Chou, C.-T. ; Chiang, C.-K. ; Chiu, W.-S. ; Chiu, T.-Y. ; Pu, Y.-S. ; Ho, I.-L. ; Wang, Z.-H. ; Chang, S.-C. ; Liu, S.-H. ; Jeng, Y.-M. ; Huang, K.-H.; CHIH-KANG CHIANG |
| 臺大學術典藏 |
2015 |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; CHIA-HSIEN CHENG; Lan K.-H.; Wang C.-C.; Wang Y.-J.;Huang C.-Y.;Hou W.-H.;Wang C.-C.;Lan K.-H.;Chen C.-H.;Yu H.-J.;Lai M.-K.;Cheng A.-L.;Liu S.-P.;Pu Y.-S.;Chia-Hsien Cheng; Wang Y.-J.; Huang C.-Y.; Hou W.-H. |
| 臺大學術典藏 |
2014 |
Metallic ureteral stents in malignant ureteral obstruction: Clinical factors predicting stent failure
|
Chow P.-M.; Hsu J.-S.; Huang C.-Y.; Wang S.-M.; Lee Y.-J.; Huang K.-H.; Yu H.-J.; Pu Y.-S.; PO-CHIN LIANG |
| 臺大學術典藏 |
2014 |
Emphysematous pyelonephritis: Clinical characteristics and prognostic factors
|
Huang C.-Y.; PO-REN HSUEH; Pu Y.-S.; Chen C.-H.; Pong Y.-H.; Chiang B.-J.; Lu Y.-C.; Lu Y.-C.;Chiang B.-J.;Pong Y.-H.;Chen C.-H.;Pu Y.-S.;Po-Ren Hsueh;Huang C.-Y. |
| 臺大學術典藏 |
2013 |
Case report
|
Chia-Chi Lin; Wang J.-Y; Pu Y.-S. |
| 臺大學術典藏 |
2013 |
Reply to S. Vale
|
Lin C.-C.; JANN-YUAN WANG; Pu Y.-S. |
| 中國醫藥大學 |
2012-11 |
Joint Effect of Arsenic Methylation Profile and NNK Metabolites on Urothelial Carcinoma
|
(Wu,C.C.);(Su,C.T.);(Lee,H.L.);鍾季容(Chi-Jung Chung);(Huang,C.Y.);(Pu,Y.S.);(Lin,P.);(Hsueh,Y.M.)* |
| 中國醫藥大學 |
2011-09 |
The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area
|
(Huang,C.Y.);(Su,C.T.);(Chu,J.S.);(Huang,S.P.);(Pu,Y.S.);(Yang,H.Y.);鍾季容(Chi-Jung Chung);(Wu,C.C.);(Hsueh,Y.M.)* |
| 中國醫藥大學 |
2011-06 |
Effect of urinary total arsenic level and estimated glomerular filtration rate on the risk of renal cell carcinoma in a low arsenic exposure area
|
(Huang,C.Y.); (Chu,J.S.); (Pu,Y.S.); (Yang,H.Y.); (Wu,C.C.); 鍾季容(Chi-Jung Chung); (Hsueh,Y.M.)* |
| 中國醫藥大學 |
2011-04 |
Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk
|
鍾季容(Chi-Jung Chung); (Lee,H.L.); (Yang H.Y.); (Lin P.); (Pu Y.S.); (Shiue H.S.); (Su C.T.); (Hsueh Y.M.)* |
| 中國醫藥大學 |
2011-01 |
Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.
|
鍾季容(Chi-Jung Chung); (Pu Y.S.); (Su C.T.); (Huang C.Y.); (Hsueh Y.M.)* |
| 中國醫藥大學 |
2011-01 |
Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
|
鍾季容(Chi-Jung Chung); (Pu Y.S.); (Chen Y.T.); (Su C.T.); (Wu C.C.,); (Shiue H.S.); (Huang C.Y.); (Hsueh Y.M.)* |
| 臺北醫學大學 |
2011 |
The Polymorphisms of P53 codon 72 and MDM2 SNP309 and Renal Cell Carcinoma Risk in a Low Arsenic Exposure Area
|
Huang, C.Y.;Su, C.T.;Chu, J.S.;Huang, S.P.;Pu, Y.S.;Yang, H.Y.;Chung, Chung C.J.;Wu, C.C.;Hsueh, Y.M. |
| 中國醫藥大學 |
2010-06 |
Polymorphisms in One-Carbon Metabolism Pathway Genes, Urinary Arsenic Profile and Urothelial Carcinoma.
|
鍾季容(Chi-Jung Chung); (Pu Y.S.); (Su C.T.,); (Chen H.W.); (Hunag Y.K.); (Shiue H.S.); (Hsueh Y.M.)* |
| 國立臺灣大學 |
2009-03 |
Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma
|
Huang, S.K.; Chiu, A.W.; Pu, Y.S.; Huang, Y.K.; Chung, C.J.; Tsai, H.J.; Yang, M.H.; Chen, C.J.; Hsueh, Y.M. |
| 中國醫藥大學 |
2009-03 |
Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
|
(Huang, S. K.); (Chiu, A. W.); (Pu, Y. S.); (Huang, Y. K.); 鍾季容(Chi-Jung Chung); (Tsai, H. J.); (Yang, M. H.); (Chen, C. J.); (Hsueh, Y. M.)* |
| 中國醫藥大學 |
2008-12 |
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
|
(Lee, H. L.); (Hsueh, Y. M.); 鍾季容(Chi-Jung Chung); (Pu, Y. S.); (Chang, L. W.); (Hsieh, D. P.); (Liou, S. H.); (Lin, P.)* |
| 中國醫藥大學 |
2008-07 |
Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
|
鍾季容(Chi-Jung Chung); (Huang, C. J.); (Pu, Y. S.); (Su, C. T.); (Huang, Y. K.); (Chen, Y. T.); (Hsueh, Y. M.)* |
| 中國醫藥大學 |
2008-06 |
Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
|
(Huang, S. K.); (Chiu, A. W.); (Pu, Y. S.); (Huang, Y. K.); 鍾季容(Chi-Jung Chung); (Tsai, H. J.); (Yang, M. H.); (Chen, C. J.); (Hsueh, Y. M.)* |
| 中國醫藥大學 |
2008-03 |
Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility.
|
(Huang, Y. K.); (Pu, Y. S.); 鍾季容(Chi-Jung Chung); (Shiue, H. S.); (Yang, M. H.); (Chen, C. J.); (Hsueh, Y. M.)* |
Showing items 571-620 of 627 (13 Page(s) Totally)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
View [10|25|50] records per page
|
